A Prospective Study Analyzing Short Term Effects of Intravitreal versus Intracameral Bevacizumab on Neovascular Glaucoma. (2024). Medical Forum Monthly, 28(4). https://medicalforummonthly.com/index.php/mfm/article/view/3985